The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Neuropsychological Change in Early Phase Schizophrenia During 12 Months of Treatment With Olanzapine, Risperidone, or Haloperidol
Abstract
BACKGROUND: The purpose of this investigation was to test the efficacy of novel antipsychotic medications in the treatment of cognitive impairment in early phase schizophrenia. METHODS: Sixty-five patients in this multicenter double-blind study were randomly assigned to olanzapine (5-20 mg), risperidone (4-10 mg), or haloperidol (5-20 mg). Standard measures of clinical and motor syndromes were administered, as well as a comprehensive battery of tests to assess (1) motor skills, (2) attention span, (3) verbal fluency and reasoning, (4) nonverbal fluency and construction, (5) executive skills, and (6) immediate recall at baseline and after 6, 30, and 54 weeks of treatment. RESULTS: The general cognitive index derived from the 6 domain scores revealed a significantly greater benefit from treatment with olanzapine relative to haloperidol and olanzapine relative to risperidone, but no significant difference was shown between risperidone and haloperidol. The improvement related to olanzapine was apparent after 6 weeks and enhanced after 30 and 54 weeks of treatment. Exploratory within-group analyses of the 6 cognitive domains after a conservative Bonferroni adjustment revealed a significant improvement with olanzapine only on the immediate recall domain, and similar analyses of the 17 individual tests revealed a significant improvement with olanzapine only on the Hooper Visual Organization Test. CONCLUSIONS: These data suggest that olanzapine has some superior cognitive benefits relative to haloperidol and risperidone. A larger sample replication study is necessary to confirm and generalize the observations of this study and begin evaluation of the implications of this change to cerebral function and quality of life for people with schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
L’examen Clinique en Psychologie
Rubé, P. (1959) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1959.13.4.989 · Cited by 3,302
A Standardized Memory Scale for Clinical Use
Wechsler, D. (1945) · The Journal of Psychology · doi:10.1080/00223980.1945.9917223 · Cited by 2,919
(1995) · Cited by 2,809
(2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_302294 · Cited by 2,278
L'examen psychologique ; Dans les cas d'ence-phalopathie traumatique (Les problemes)
Rey, A. (1941) · Medical Entomology and Zoology · Cited by 1,702
Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort
JONES, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90569-x · Cited by 1,353
Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia
Saykin, A. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020048005 · Cited by 1,086
CHOUINARD, G., JONES, B., REMINGTON, G., BLOOM, D., ADDINGTON, D., MacEWAN, G. W., LABELLE, A., BEAUCLAIR, L., & ARNOTT, W. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199302000-00004 · Cited by 876
(2016) · The SAGE Encyclopedia of Theory in Psychology · doi:10.4135/9781483346274.n39 · Cited by 745
Design fluency: The invention of nonsense drawings after focal cortical lesions
Jones-Gotman, M., & Milner, B. (1977) · Neuropsychologia · doi:10.1016/0028-3932(77)90070-7 · Cited by 584
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Crow, T. J. (1980) · British Journal of Psychiatry · doi:10.1192/s0007125000071919 · Cited by 562
Is it possible to be schizophrenic yet neuropsychologically normal?
Palmer, B. W., Heaton, R. K., Paulsen, J. S., Kuck, J., Harris, M. J., Zisook, S., & Jeste, D. V. (1997) · Neuropsychology · doi:10.1037//0894-4105.11.3.437 · Cited by 529
Ruff, R. M., & Parker, S. B. (1993) · Perceptual and Motor Skills · doi:10.2466/pms.1993.76.3c.1219 · Cited by 488
KOLB, B., & WHISHAW, I. Q. (1983) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198307000-00008 · Cited by 463
Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.799 · Cited by 397
Hagger, C., Buckley, P., Kenny, J. T., Friedman, L., Ubogy, D., & Meltzer, H. Y. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90043-d · Cited by 393
Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.
Spohn, H. E., & Strauss, M. E. (1989) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.98.4.367 · Cited by 381
Neuropsychological functioning of first-episode schizophreniform patients
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.7.898 · Cited by 322
Buchanan, R. W., Holstein, C., & Breier, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90082-5 · Cited by 281
Neuroleptics: Effects on Neuropsychological Function in Chronic Schizophrenic Patients
Cassens, G., Inglis, A. K., Appelbaum, P. S., & Gutheil, T. G. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.477 · Cited by 271
Rey complex figure test under four different administration procedures
Meyers, J. E., & Meyers, K. R. (1995) · The Clinical Neuropsychologist · doi:10.1080/13854049508402059 · Cited by 255
Effects of clozapine on cognitive function in schizophrenia.
Lee, M. A., Thompson, P. A., & Meltzer, H. Y. (1994) · PubMed · Cited by 196
Bakshi, V. P., & Geyer, M. A. (1995) · Psychopharmacology · doi:10.1007/bf02246096 · Cited by 189
Bilder, R. M., Bogerts, B., Ashtari, M., Wu, H., Alvir, J. M., Jody, D., Reiter, G., Bell, L., & Lieberman, J. A. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00028-k · Cited by 181
Neuropsychological and Psychophysiological Correlates of Psychosocial Functioning in Schizophrenia
Brekke, J. S., Raine, A., Ansel, M., Lencz, T., & Bird, L. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.1.19 · Cited by 179
Seroquel restores sensorimotor gating in phencyclidine-treated rats.
Swerdlow, N. R., Bakshi, V. P., & Geyer, M. A. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21289-7 · Cited by 154
Effects of Olanzapine on Regional C-Fos Expression in Rat Forebrain
Robertson, G. S., & Fibiger, H. C. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00196-k · Cited by 132
Test-retest reliability of a new form of the auditory verbal learning test (AVLT)
Geffen, G. M., Butterworth, P., & Geffen, L. B. (1994) · Archives of Clinical Neuropsychology · doi:10.1016/0887-6177(94)90018-3 · Cited by 126
Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study
Rossi, A., Mancini, F., Stratta, P., et al. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb00371.x · Cited by 120
Neuropsychiatric rehabilitation for persistent mental illness
Jaeger, J., & Douglas, E. (1992) · Psychiatric Quarterly · doi:10.1007/bf01064683 · Cited by 106
Antipsychotic medication effects on neuropsychological functions.
Bilder, R. M., Turkel, E., Lipschutz-Broch, L., & Lieberman, J. A. (1992) · PubMed · Cited by 104
Cognitive improvement in schizophrenia with novel antipsychotic medications
Purdon, S. E. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00166-2 · Cited by 96
Self-citationVolonté, M., Monferini, E., Cerutti, M., Fodritto, F., & Borsini, F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010182.x · Cited by 88
Neurocognitive Impairment in Schizophrenia and how it Affects Treatment Options
Bilder, R. M. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200303 · Cited by 85
Risperidone in the Treatment of Pervasive Developmental Disorder
Purdon, S. E., Lit, W., Labelle, A., & Jones, B. (1994) · The Canadian Journal of Psychiatry · doi:10.1177/070674379403900703 · Cited by 78
Self-citationSchizophrenia, memory, and anticholinergic drugs.
Frith, C. (1984) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.93.3.339 · Cited by 48
Interrater reliability of scoring parameters for the Design Fluency Test.
Woodard, J. L., Axelrod, B. N., & Henry, R. R. (1992) · Neuropsychology · doi:10.1037//0894-4105.6.2.173 · Cited by 15
(1985) · doi:10.1002/1097-4679(198509)41:5
Cited by
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
Correll, C. U., Leucht, S., & Kane, J. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.414 · Cited by 709
Bilder, R. M., Goldman, R. S., Volavka, J., Czobor, P., Hoptman, M., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J., Kunz, M., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1018 · Cited by 538
Early intervention for psychosis
Marshall, M., & Rathbone, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004718.pub3 · Cited by 531
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
Kreyenbuhl, J., Buchanan, R. W., Dickerson, F. B., & Dixon, L. B. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp130 · Cited by 499
Metadata
- Authors
- Purdon, S. E.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2000-03-01
- Volume
- 57
- Issue
- 3
- Pages
- 249
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2041495183
- Cited by
- 469
- References
- 39
- FWCI
- 34.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.